Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resistance rates among antiretroviral regimens in pregnant people living with HIV.
da Silveira Gouvêa MIF, de Lourdes Benamor Teixeira M, Fuller T, Sodré MCMP, Medeiros AF, de Mattos Salgueiro M, da Silveira Bressan C, Braga CM, da Silva PA, Mendes-Silva W, Moreira C, Jundi F, Cruz ML, Ceci L, Lattanzi FP, João EC. da Silveira Gouvêa MIF, et al. Among authors: joao ec. HIV Med. 2023 Sep;24(9):1020-1025. doi: 10.1111/hiv.13498. Epub 2023 May 4. HIV Med. 2023. PMID: 37143179
Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years.
Nachman S, Zheng N, Acosta EP, Teppler H, Homony B, Graham B, Fenton T, Xu X, Wenning L, Spector SA, Frenkel LM, Alvero C, Worrell C, Handelsman E, Wiznia A; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1066 Study Team. Nachman S, et al. Clin Infect Dis. 2014 Feb;58(3):413-22. doi: 10.1093/cid/cit696. Epub 2013 Oct 21. Clin Infect Dis. 2014. PMID: 24145879 Free PMC article. Clinical Trial.
Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study.
Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Kakuda TN, Nijs S, Tambuyzer L, Tomaka FL; PIANO study group. Tudor-Williams G, et al. HIV Med. 2014 Oct;15(9):513-24. doi: 10.1111/hiv.12141. Epub 2014 Mar 3. HIV Med. 2014. PMID: 24589294 Free article. Clinical Trial.
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
João EC, Morrison RL, Shapiro DE, Chakhtoura N, Gouvèa MIS, de Lourdes B Teixeira M, Fuller TL, Mmbaga BT, Ngocho JS, Njau BN, Violari A, Mathiba R, Essack Z, Pilotto JHS, Moreira LF, Rolon MJ, Cahn P, Prommas S, Cressey TR, Chokephaibulkit K, Werarak P, Laimon L, Hennessy R, Frenkel LM, Anthony P, Best BM, Siberry GK, Mirochnick M. João EC, et al. Lancet HIV. 2020 May;7(5):e322-e331. doi: 10.1016/S2352-3018(20)30038-2. Lancet HIV. 2020. PMID: 32386720 Free PMC article. Clinical Trial.
Efficacy of Three Antiretroviral Regimens Initiated during Pregnancy: Clinical Experience in Rio de Janeiro.
Benamor Teixeira ML, Fuller TL, Fragoso Da Silveira Gouvêa MI, Santos Cruz ML, Ceci L, Pinheiro Lattanzi F, Sidi LC, Mendes-Silva W, Nielsen-Saines K, Joao EC. Benamor Teixeira ML, et al. Among authors: joao ec. Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01068-20. doi: 10.1128/AAC.01068-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 33020151 Free PMC article.
Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial.
Frenkel LM, Morrison RL, Fuller TL, Gouvêa MI, Benamor Teixeira ML, Coombs RW, Shapiro DE, Mirochnick M, Hennessey R, Whitson K, Chakhtoura N, João EC. Frenkel LM, et al. Among authors: joao ec. J Acquir Immune Defic Syndr. 2021 Dec 1;88(4):361-365. doi: 10.1097/QAI.0000000000002771. J Acquir Immune Defic Syndr. 2021. PMID: 34369908 Free PMC article. Clinical Trial.
65 results